Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation

v3.22.1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2022
Stock-Based Compensation  
Note 7 - Stock-based Compensation

Note 7 – Stock-Based Compensation

 

a) Warrants

 

The following table summarizes the changes in warrants outstanding of the Company during the three-month period ended March 31, 2022:

 

 

 

 

 

 

 

Weighted

Average

 

 

 

Number of

Warrants

 

 

Exercise

Price ($)

 

Outstanding at December 31, 2021

 

 

485,000

 

 

 

3.88

 

Granted

 

 

-

 

 

 

-

 

Outstanding at March 31, 2022

 

 

485,000

 

 

 

3.88

 

 

 

 

 

 

 

 

 

 

Exercisable at March 31, 2022

 

 

485,000

 

 

 

3.88

 

 

Below is a table summarizing the warrants issued and outstanding as of March 31, 2022, which have an aggregate weighted average remaining contractual life of 3.71 years.

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

Proceeds to

 

Number

 

 

Number

 

 

Exercise

 

 

Contractual

 

 

Company if

 

Outstanding

 

 

Exercisable

 

 

Price ($)

 

 

Life (Years)

 

 

Exercised ($)

 

 

125,000

 

 

 

125,000

 

 

 

2.47

 

 

 

0.91

 

 

 

308,750

 

 

50,000

 

 

 

50,000

 

 

 

3.45

 

 

 

3.92

 

 

 

172,500

 

 

125,000

 

 

 

125,000

 

 

 

3.95

 

 

 

4.76

 

 

 

493,750

 

 

185,000

 

 

 

185,000

 

 

 

4.90

 

 

 

4.84

 

 

 

906,500

 

 

485,000

 

 

 

485,000

 

 

 

 

 

 

 

 

 

 

 

1,881,500

 

Stock-based compensation expense related to warrants of $39,013 and $148,364 was recorded in the three months ended March 31, 2022 and March 31, 2021, respectively. There is no remaining expense to be recognized. As of March 31, 2022, the total intrinsic value of warrants outstanding was $67,500.

 

b) Options

 

The following table summarizes the changes in options outstanding of the Company during the three-month period ended March 31, 2022:

 

 

 

 

 

 

Weighted Average

 

 

 

Number of

Options

 

 

Exercise Price ($)

 

Outstanding at December 31, 2021

 

 

5,027,518

 

 

 

3.87

 

Granted

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

Expired/Cancelled

 

 

-

 

 

 

-

 

Outstanding at March 31, 2022

 

 

5,027,518

 

 

 

3.87

 

 

 

 

 

 

 

 

 

 

Exercisable at March 31, 2022

 

 

3,937,518

 

 

 

4.00

 

 

.

Below is a table summarizing the options issued and outstanding as of March 31, 2022, all of which were issued pursuant to the 2011 Equity Incentive Plan (for option issuances prior to 2016) or the 2015 Stock Incentive Plan (for option issuances commencing in 2016) and which have an aggregate weighted average remaining contractual life of 6.00 years. As of March 31, 2022, an aggregate of 6,000,000 shares of common stock were authorized for issuance under the 2015 Stock Incentive Plan, of which 336,352 shares of common stock remained available for future issuance thereunder.

 

 

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

Proceeds to

 

Number

 

 

Number

 

 

Exercise

 

 

Contractual

 

 

Company if

 

Outstanding

 

 

Exercisable

 

 

Price ($)

 

 

Life (Years)

 

 

Exercised ($)

 

635,000

 

 

635,000

 

 

3.25

 

 

2.87

 

 

2,063,750

 

2,717

 

 

2,717

 

 

3.35

 

 

1.42

 

 

9,102

 

1,060,000

 

 

10,000

 

 

3.40

 

 

9.35

 

 

3,604,000

 

800,000

 

 

760,000

 

 

3.60

 

 

8.10

 

 

2,880,000

 

1,682,837

 

 

1,682,837

 

 

4.00

 

 

4.51

 

 

6,731,348

 

11,801

 

 

11,801

 

 

4.35

 

 

1.20

 

 

51,334

 

89,163

 

 

89,163

 

 

4.38

 

 

5.82

 

 

390,534

 

50,000

 

 

50,000

 

 

4.80

 

 

4.76

 

 

240,000

 

696,000

 

 

696,000

 

 

5.00

 

 

4.99

 

 

3,480,000

 

5,027,518

 

 

3,937,518

 

 

 

 

 

 

 

 

19,450,068

 

Stock-based compensation expense related to stock options of $394,053 and $355,076 was recorded in the three months ended March 31, 2022 and March 31, 2021, respectively. Total remaining unrecognized compensation cost related to non-vested stock options is $1,064,229 and is expected to be recognized over a period of 1.51 years. As of March 31, 2022, the total intrinsic value of stock options outstanding was $nil.

 

c) Restricted Stock Units (RSUs)

 

Below is a table summarizing the RSUs issued and outstanding as of March 31, 2022, all of which were issued pursuant to the 2015 Stock Incentive Plan.

 

 

 

Number of

 

 

Weighted Average

 

 

 

RSUs

 

 

Share Price ($)

 

Outstanding at December 31, 2021

 

 

810,750

 

 

 

3.33

 

Granted

 

 

38,000

 

 

 

2.81

 

Vested/Settled

 

 

(15,000 )

 

 

3.59

 

Cancelled

 

 

-

 

 

 

-

 

Outstanding at March 31, 2022

 

 

833,750

 

 

 

3.30

 

 

Effective February 8, 2022, the Company granted aggregate RSUs of 8,000 shares of common stock to an employee in exchange for services provided to the Company. These RSUs vest over two years, with 50% vesting on each of February 8, 2023 and February 8, 2024, subject to continued service, and will result in total compensation expense of $22,640.

 

Effective March 1, 2022, the Company granted aggregate RSUs of 30,000 shares of common stock to various employees in exchange for services provided to the Company. These RSUs vest over two years, with 50% vesting on each of March 1, 2023 and March 1, 2024, subject to continued service, and will result in total compensation expense of $84,300.

 

On March 28, 2022, 15,000 RSUs vested and resulted in the issuance of 15,000 shares of common stock.

Below is a table summarizing the RSUs issued and outstanding as of March 31, 2022 and which have an aggregate weighted average remaining contractual life of 0.92 years.

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

Remaining

 

Number

 

 

Share

 

 

Contractual

 

Outstanding

 

 

Price ($)

 

 

Life (Years)

 

30,000

 

 

2.81

 

 

1.42

 

8,000

 

 

2.83

 

 

1.36

 

39,809

 

 

3.04

 

 

1.01

 

610,191

 

 

3.31

 

 

0.86

 

38,000

 

 

3.32

 

 

0.94

 

23,000

 

 

3.38

 

 

1.21

 

43,500

 

 

3.51

 

 

1.09

 

26,250

 

 

3.52

 

 

0.04

 

15,000

 

 

3.59

 

 

0.98

 

833,750

 

 

 

 

 

 

 

 

Stock-based compensation expense related to RSUs of $481,962 and $51,902 was recorded in the three months ended March 31, 2022 and March 31, 2021, respectively. Total remaining unrecognized compensation cost related to non-vested RSUs is $1,435,500. As of March 31, 2022, the total intrinsic value of the RSUs outstanding was $7,440.